China Pharma (NYSE:CPHI) Coverage Initiated at StockNews.com

Stock analysts at StockNews.com initiated coverage on shares of China Pharma (NYSE:CPHI) in a report released on Saturday. The firm set a “hold” rating on the stock.

China Pharma Price Performance

Shares of NYSE CPHI opened at $0.20 on Friday. China Pharma has a 52-week low of $0.13 and a 52-week high of $0.60. The company has a debt-to-equity ratio of 0.22, a quick ratio of 0.26 and a current ratio of 0.79. The stock’s fifty day simple moving average is $0.20 and its 200 day simple moving average is $0.22.

About China Pharma

China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People’s Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.